RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
CLINICAL LUNG CANCER
Collezione AOU San Luigi di Orbassano

Items : 21

Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma. in Clinical lung cancer / Clin Lung Cancer. 2025 Jan 9:S1525-7304(25)00002-6. doi: 10.1016/j.cllc.2025.01.001.

2025
AOU San Luigi di Orbassano

Tajè R; Ambrogi V; Tacconi F; Gallina FT; Alessandrini G; Forcella D; Buglioni S; Visca P; Patirelis A; Cecere FL; Melis E; Vidiri A; Sperduti I; Cappuzzo F; Novello S; Caterino M; Facciolo F;

Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response. in Clinical lung cancer / Clin Lung Cancer. 2022 Sep;23(6):e347-e352. doi: 10.1016/j.cllc.2022.05.007. Epub 2022 May 11.

2022
AOU San Luigi di Orbassano

Bironzo P; Primo L; Novello S; Righi L; Candeloro S; Manganaro L; Bussolino F; Pirri F; Scagliotti GV;

PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients. in Clinical lung cancer / Clin Lung Cancer. 2022 May;23(3):e243-e246. doi: 10.1016/j.cllc.2021.07.008. Epub 2021 Jul 20.

2022
AOU San Luigi di Orbassano

Remon J; Girard N; Novello S; de Castro J; Bigay-Game L; Bernabé R; Greillier L; Mosquera J; Cousin S; Juan O; Sampayo M; Besse B; Remon J; Girard N; Novello S; de Castro J; Bigay-Game L; Bernabé R; Greillier L; Mosquera J; Cousin S; Juan O; Sampayo M; Besse B;

A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design. in Clinical lung cancer / Clin Lung Cancer. 2021 Jan;22(1):e63-e66. doi: 10.1016/j.cllc.2020.07.014. Epub 2020 Aug 5.

2021
AOU San Luigi di Orbassano

Scagliotti GV; Volante M; Novello S; Arizio F; Listì A; Righi L; Passiglia F; Bironzo P;

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ? 50% and Their Relationship With Clinical Outcomes. in Clinical lung cancer / Clin Lung Cancer. 2020 Nov;21(6):498-508.e2. doi: 10.1016/j.cllc.2020.06.010. Epub 2020 Jun 21.

2020
AOU San Luigi di Orbassano

Cortellini A; Friedlaender A; Banna GL; Porzio G; Bersanelli M; Cappuzzo F; Aerts JGJV; Giusti R; Bria E; Cortinovis D; Grossi F; Migliorino MR; Galetta D; Passiglia F; Berardi R; Mazzoni F; Di Noia V; Signorelli D; Tuzi A; Gelibter A; Marchetti P; Macerelli M; Rastelli F; Chiari R; Rocco D; Inno A; Di Marino P; Mansueto G; Zoratto F; et alii...

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy. in Clinical lung cancer / Clin Lung Cancer. 2018 Sep;19(5):377-386. doi: 10.1016/j.cllc.2018.03.004. Epub 2018 Mar 17.

2018
AOU San Luigi di Orbassano

Shukla ND; Salahudeen AA; Taylor GA; Ramalingam SS; Vokes EE; Goss GD; Decker RH; Kelly K; Scagliotti GV; Mok TS; Wakelee HA;

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sperduti I; Aglietta M; Cagnazzo C; Di Stefano TS; Di Costanzo A; Matocci R; Chiari R; Petrillo P; Galetta D; Arizio F; Di Maio M; Polo V; Pasello G; Pilotto S; Gobbini E; Bria E; Novello S; Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; et alii...

The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613. in Clinical lung cancer / Clin Lung Cancer. 2017 Sep;18(5):583-588. doi: 10.1016/j.cllc.2017.02.005. Epub 2017 Mar 1.

2017
AOU San Luigi di Orbassano

Remon J; Menis J; Hasan B; Peric A; De Maio E; Novello S; Reck M; Berghmans T; Wasag B; Besse B; Dziadziuszko R;

Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis. in Clinical lung cancer / Clin Lung Cancer. 2017 Jan;18(1):23-33.e1. doi: 10.1016/j.cllc.2016.08.006. Epub 2016 Oct 28.

2017
AOU San Luigi di Orbassano

La Salvia A; Rossi A; Galetta D; Gobbini E; De Luca E; Novello S; Di Maio M;

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2017 Jan;18(1):50-59. doi: 10.1016/j.cllc.2016.09.013. Epub 2016 Oct 19.

2017
AOU San Luigi di Orbassano

Wakelee H; Zvirbule Z; De Braud F; Kingsley CD; Mekhail T; Lowe T; Schütte W; Lena H; Lawler W; Braiteh F; Cosgriff T; Kaen D; Boyer M; Hsu J; Phan S; Novello S;

Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study. in Clinical lung cancer / Clin Lung Cancer. 2014 Sep;15(5):338-45.e1. doi: 10.1016/j.cllc.2014.04.004. Epub 2014 May 14.

2014
AOU San Luigi di Orbassano

de Marinis F; Ardizzoni A; Fontanini G; Grossi F; Cappuzzo F; Novello S; Santo A; Lorusso V; Cortinovis D; Iurlaro M; Galetta D; Gridelli C;

Early response to chemotherapy in patients with non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. in Clinical lung cancer / Clin Lung Cancer. 2013 May;14(3):230-7. doi: 10.1016/j.cllc.2012.10.004. Epub 2012 Dec 29.

2013
AOU San Luigi di Orbassano

Novello S; Vavalà T; Levra MG; Solitro F; Pelosi E; Veltri A; Scagliotti GV;

Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography. in Clinical lung cancer / Clin Lung Cancer. 2013 Mar;14(2):139-48. doi: 10.1016/j.cllc.2012.05.005. Epub 2012 Aug 4.

2013
AOU San Luigi di Orbassano

Priola AM; Priola SM; Giaj-Levra M; Basso E; Veltri A; Fava C; Cardinale L;

Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2012 Sep;13(5):391-5. doi: 10.1016/j.cllc.2012.01.003. Epub 2012 Mar 21.

2012
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Schiller JH; Hirsh V; Sequist LV; Soria JC; von Pawel J; Schwartz B; Von Roemeling R; Sandler AB;

Primary pleuropulmonary sarcoma: a rare disease entity. in Clinical lung cancer / Clin Lung Cancer. 2012 Nov;13(6):399-407. doi: 10.1016/j.cllc.2012.05.003. Epub 2012 Jun 5.

2012
AOU San Luigi di Orbassano

Giaj Levra M; Novello S; Scagliotti GV; Papotti M; Le Cesne A;

Role of hormone receptor expression in patients with advanced-stage lung cancer treated with chemotherapy. in Clinical lung cancer / Clin Lung Cancer. 2012 Nov;13(6):416-23. doi: 10.1016/j.cllc.2012.03.006. Epub 2012 Jun 2.

2012
AOU San Luigi di Orbassano

Monica V; Longo M; Felice B; Scagliotti GV; Papotti M; Novello S;

New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2008;9 Suppl 3:S122-8. doi: 10.3816/CLC.2008.s.018.

2008
AOU San Luigi di Orbassano

Scagliotti GV; Selvaggi G;

Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2007 Jan;8(4):264-7. doi: 10.3816/CLC.2007.n.004.

2007
AOU San Luigi di Orbassano

Zecchina G; Ghio P; Bosio S; Cravino M; Camaschella C; Scagliotti GV;

The way forward: new drugs and new therapeutic strategies in lung cancer therapy. in Clinical lung cancer / Clin Lung Cancer. 2006 May;7 Suppl 4:S109-10. doi: 10.3816/clc.2006.s.001.

2006
AOU San Luigi di Orbassano

Scagliotti GV; Novello S;

Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2006 May;7(6):395-400. doi: 10.3816/CLC.2006.n.023.

2006
AOU San Luigi di Orbassano

Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV;

Current development of adjuvant treatment of non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2004 Dec;6 Suppl 2:S63-70. doi: 10.3816/clc.2004.s.016.

2004
AOU San Luigi di Orbassano

Scagliotti GV; Novello S;